08925-cover | Chemical & Engineering News
Volume 89 Issue 25 | pp. 15-20
Issue Date: June 20, 2011


The end of a partnership with big pharma brings both opportunity and challenge for biotech firms
Department: Business
Keywords: Exelixis, biotech, Aveo, Targacept, Rigel

BreakUps High-profile biotech deals became casualties of big pharma’s shifting priorities.

February 2010: Merck/Anacor

June 2010: BMS/Exelixis

October 2010: Merck/Aveo

February 2011: Merck/Galapagos

March 2011: Merck/Portola

March 2011: GSK/Targacept

May 2011: Pfizer/Rigel

May 2011: AstraZeneca/Targacept

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment